{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:36:37Z","timestamp":1788791797183,"version":"build-2803163510"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Glioma is the most common primary intracranial neoplasm with a relatively poor prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>Here, we present a unique case of a 53-year-old woman with two histopathologically distinct gliomas at the initial diagnosis. She presented with headaches and left limb weakness before admission, and magnetic resonance imaging (MRI) showed right frontal and basal ganglia area involvement combined with hemorrhage. The patient underwent a navigation-guided craniotomy for tumor removal. Pathological examination revealed the right frontal lobe lesion as a WHO grade II IDH-NOS astrocytoma, but the right parietal lobe lesion was a WHO grade IV IDH-mutant diffuse astrocytoma. Molecular detection of the parietal lesion revealed a point mutation at the R132 locus of the <jats:italic>IDH1<\/jats:italic> gene, no mutation in the <jats:italic>TERT<\/jats:italic> promoter, amplification of the epidermal growth factor receptor, and a non-homozygous <jats:italic>CDKN2A\/B<\/jats:italic> deletion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In-depth epigenomic analysis and molecular examination revealed that one patient had two different brain tumors, underscoring the importance of performing a comprehensive brain tumor workup.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This unique case confirms that adjacent astrocytomas may have different molecular pathogenesis and provides novel insights into the development of gliomas.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1308497","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:52:53Z","timestamp":1718196773000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: A 53-year-old woman with synchronous WHO classification II and IV gliomas"],"prefix":"10.3389","volume":"14","author":[{"given":"Fang","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02127-9","article-title":"cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas","volume":"139","author":"Brat","year":"2020","journal-title":"Acta Neuropathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"15330338221109650","DOI":"10.1177\/15330338221109650","article-title":"Pattern of recurrence of glioblastoma versus grade 4 IDH-mutant astrocytoma following chemoradiation: A retrospective matched-cohort analysis","volume":"21","author":"Stewart","year":"2022","journal-title":"Technol Cancer Res Treat"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-021-03870-z","article-title":"Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant","volume":"155","author":"Sohn","year":"2021","journal-title":"J Neurooncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00778-x","article-title":"Molecular landscape of IDH-mutant primary astrocytoma Grade IV\/glioblastomas","volume":"34","author":"Wong","year":"2021","journal-title":"Mod Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/neuonc\/noac205","article-title":"Translational significance of CDKN2A\/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma","volume":"25","author":"Ensign","year":"2023","journal-title":"Neuro-Oncology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3171\/2013.2.JNS121747","article-title":"Surgical management of multicentric diffuse low-grade gliomas: functional and oncological outcomes: clinical article","volume":"118","author":"Terakawa","year":"2013","journal-title":"J Neurosurg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s40478-021-01265-9","article-title":"Synchronous supratentorial and infratentorial oligodendrogliomas with incongruous IDH1 mutations, a case report","volume":"9","author":"Agopyan-Miu","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2012.01.012","article-title":"Management of multifocal and multicentric gliomas","volume":"23","author":"Patil","year":"2012","journal-title":"Neurosurg Clin N Am"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.939523","article-title":"Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz124","article-title":"CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse Malignant IDH-mutant gliomas","volume":"21","author":"Appay","year":"2019","journal-title":"Neuro-Oncology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/107327481502200211","article-title":"Impending impact of molecular pathology on classifying adult diffuse gliomas","volume":"22","author":"Macaulay","year":"2015","journal-title":"Cancer Control"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.04.014","article-title":"Adult brainstem gliomas: Correlation of clinical and molecular features","volume":"353","author":"Theeler","year":"2015","journal-title":"J Neurol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2571-0","article-title":"Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria","volume":"135","author":"Visani","year":"2017","journal-title":"J Neuro-Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1996.tb00848.x","article-title":"Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas","volume":"6","author":"Watanabe","year":"1996","journal-title":"Brain Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/02688697.2020.1837733","article-title":"IDH-wildtype secondary glioblastoma arising in IDH-mutant diffuse astrocytoma: a case report","volume":"37","author":"Yoon","year":"2023","journal-title":"Br J Neurosurg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.04.004","article-title":"Exosomes in cancer development, metastasis, and immunity","volume":"1871","author":"Zhang","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1018840","article-title":"Case report: Two unique cases of co-existing primary brain tumors of glial origin in opposite hemispheres","volume":"12","author":"Singhal","year":"2022","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01251-6","article-title":"Updates in IDH-wildtype glioblastoma","volume":"19","author":"Melhem","year":"2022","journal-title":"Neurotherapeutics"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1308497\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:52:58Z","timestamp":1718196778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1308497\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":20,"alternative-id":["10.3389\/fonc.2024.1308497"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1308497","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"article-number":"1308497"}}